Singham Returns Sets New Box Office Records for Ajay Devgn, Rohit Shetty
Singham Returns continued its good performance at the box office, helping actor Ajay Devgn and director Rohit Shetty set new benchmarks.
Singham Returns grossed Rs 8.21 crore on Tuesday, taking its India business tally to Rs 100.68 crore, trade analyst Taran Adarsh tweeted.
This makes Singham Returns Ajay Devgn's fifth Rs 100 crore grosser, Mr Adarsh added. Singham Returns also marks director Rohit Shetty's fifth Rs 100 crore grosser, Mr Adarsh said. Rohit Shetty has delivered hits like Golmaal series, Singham, Bol Bachchan and Chennai Express.
Singham Returns' prequel Singham had also done business of nearly Rs 100 crore. Singham Returns, which was released on Independence Day, had hit the Rs.50 crore-mark in just two days.
Singham Returns had opened to 4,020 screens worldwide, 3,610 in India and 410 overseas, added Mr Adarsh.
Singham Returns has also got a strong reception at overseas box office. According to Eros, which distributed Singham Returns in the overseas markets, the action thriller grossed nearly Rs 15 crore in its first weekend.
Singham Returns is co-produced by Ajay Devgn Films, Rohit Shetty Productions and Reliance Entertainment. (With Agency Inputs)
Â
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.